Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Dura Substitutes Market Size, Share & Trends Analysis Report By Type, By Region, And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global dura substitutes market size is anticipated to reach USD 287.68 million by 2030 and is projected to grow at a CAGR of 3.63% over the forecast period.
The dura substitute industry is experiencing significant growth due to the increasing prevalence of neurosurgical disorders worldwide. According to an article published by the World Federation of Neurology in October 2023, a recent Global Burden of Disease (GBD) study reveals that neurological disorders are the second leading cause of death and the primary cause of disability globally. Currently, over 40% of the population is affected by these conditions, with projections indicating this prevalence can almost double by 2050. 
Moreover, the global aging population, rising incidence of traumatic brain injuries, and central nervous system tumors requiring surgical interventions are driving demand for these products. According to the United Nations, in January 2023, the global geriatric population aged 65 years and above is expected to increase from 761 million in 2021 to approximately 1.6 billion in 2050. This elderly population is more vulnerable to neurological disorders, which can increase the demand for neurological procedures. In addition, advancements in neurosurgical techniques, including minimally invasive procedures, have increased the need for biocompatible and effective dura substitutes.
Moreover, the adoption of synthetic dura substitutes is gaining traction due to their superior properties compared to traditional autologous grafts. Synthetic substitutes, such as those made from expanded polytetrafluoroethylene (ePTFE) or silicone, offer consistent quality, reduced operative time, and minimized donor-site morbidity. Meanwhile, biological substitutes derived from bovine or porcine sources are preferred in cases requiring high biocompatibility and reduced immune response. The combination of expanding clinical applications and an increasing focus on patient safety is significantly driving the market for these advanced materials, enabling better acceptance in both developed and emerging economies.
Regulatory approvals and favorable reimbursement policies are also positively contributing to market growth. Agencies such as the FDA and European CE are recognizing dura substitutes, ensuring their safety and efficacy for a broad range of neurosurgical applications. Moreover, growing awareness among healthcare providers regarding the benefits of these substitutes, including reduced postoperative complications and faster recovery times, has further increased their adoption in hospitals and specialized surgical centers, which is further expected to drive the market growth over the forecast period.
Dura Substitutes Market Report Highlights
- Based on type, the biological dura substitutes segment dominated the industry with the largest revenue share owing to its several advantages, such as its biodegradable nature and ability to effectively integrate with native tissues.
- North America held the largest market share of 32.89% in 2024. This can be attributed to increasing awareness about post-surgical healing, developed healthcare infrastructure, presence of key market players, and access to advanced dura substitute solutions.
- Market players operating in dura substitutes market include Medtronic, B. Braun, Stryker, DePuy Synthes (Johnson & Johnson), W. L. Gore & Associates, Acera Surgical, Severn Healthcare Technologies, Integra Lifesciences and Gunze
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 120 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $232.27 million |
| Forecasted Market Value (USD) by 2030 | $287.68 million |
| Compound Annual Growth Rate | 3.6% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Dura Substitutes Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Incidents of Neurological Disorders
3.2.1.2. Rising Awareness About Minimally Invasive Procedures
3.2.1.3. Growing Geriatric Population
3.2.1.4. Increasing Regulatory Support
3.2.2. Market Restraint Analysis
3.2.2.1. Risk of Complications and Safety Concerns
3.2.2.2. High Cost of Dura Substitutes
3.2.3. Market Opportunities Analysis
3.2.3.1. Expansion in Emerging Markets
3.2.4. Market Challenge Analysis
3.2.4.1. Limited Availability of High-Quality Biological Materials
3.3. Dura Substitutes Market Analysis Tools
Chapter 4. Dura Substitutes Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Dura Substitutes Market Type Movement Analysis
4.3. Dura Substitutes Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Biological Dura Substitutes
4.5. Synthetic Dura Substitutes
Chapter 5. Dura Substitutes Market: Regional Estimates & Trend Analysis By Type
5.1. Regional Dashboard
5.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
5.3. North America
5.4. Europe
5.5. Asia Pacific
5.6. Latin America
5.7. Middle East & Africa
Chapter 6. Competitive Landscape
6.1. Market Participant Categorization
6.2. Key Company Profiles
- Medtronic
- B. Braun
- Stryker
- DePuy Synthes (Johnson & Johnson)
- W. L. Gore & Associates, Inc.
- Acera Surgical Inc.
- Severn Healthcare Technologies Limited.
- Integra Lifesciences
- Gunze
For more information about this report visit https://www.researchandmarkets.com/r/u2e8xy
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
